• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

90天内不良事件的主动监测:胰十二指肠切除术后手术结果报告的标准

Active Surveillance for Adverse Events Within 90 Days: The Standard for Reporting Surgical Outcomes After Pancreatectomy.

作者信息

Schwarz Lilian, Bruno Morgan, Parker Nathan H, Prakash Laura, Mise Yoshihiro, Lee Jeffrey E, Vauthey Jean-Nicolas, Aloia Thomas A, Conrad Claudius, Fleming Jason B, Katz Matthew H G

机构信息

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Ann Surg Oncol. 2015 Oct;22(11):3522-9. doi: 10.1245/s10434-015-4437-z. Epub 2015 Feb 19.

DOI:10.1245/s10434-015-4437-z
PMID:25694246
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12047848/
Abstract

BACKGROUND

The rate of adverse events after pancreatectomy is widely reported as a measure of surgical quality. However, morbidity data are routinely acquired retrospectively and often are reported at 30 days. The authors hypothesized that morbidity after pancreatectomy is therefore underreported. They sought to compare rates of adverse events calculated at multiple time points after pancreatectomy.

METHODS

The authors instituted an active surveillance system to detect, categorize, and grade the severity of all adverse events after pancreatectomy, using the modified Accordion system and International Study Group of Pancreatic Surgery definitions. All patients and clinical events were monitored directly for at least 90 days after surgery.

RESULTS

Of 315 consecutively monitored patients, 239 (76 %) experienced 500 unique adverse events. The absolute number of unique adverse events increased by 32 % between index discharge and 90 days and by 10 % between 30 and 90 days. The number of severe adverse events increased by 96 % between discharge and 90 days and by 29 % between 30 and 90 days. In this study, 16 % of the patients experienced at least one severe adverse event within the index hospitalization, 24 % within 30 postoperative days, and 29 % within 90 days. Among the 80 readmissions that occurred within 90 days, 28 (35 %) occurred later than 30 days after pancreatectomy.

CONCLUSIONS

Approximately one-third of severe adverse events and readmissions are reported more than 30 days after surgery. All adverse events that occur within 90 days of surgery must be identified and reported for accurate characterization of the morbidity associated with pancreatectomy.

摘要

背景

胰腺切除术后不良事件发生率被广泛报道,作为衡量手术质量的一项指标。然而,发病率数据通常是通过回顾性收集的,且常常报告的是术后30天的数据。作者推测,胰腺切除术后的发病率因此被低估了。他们试图比较胰腺切除术后多个时间点计算出的不良事件发生率。

方法

作者建立了一个主动监测系统,使用改良的手风琴系统和国际胰腺手术研究组的定义,来检测、分类和分级胰腺切除术后所有不良事件的严重程度。所有患者和临床事件在术后至少90天内进行直接监测。

结果

在315例连续监测的患者中,239例(76%)发生了500起不同的不良事件。从出院时到90天,不同不良事件的绝对数量增加了32%,从30天到90天增加了10%。严重不良事件的数量从出院时到90天增加了96%,从30天到90天增加了29%。在本研究中,16%的患者在首次住院期间发生了至少1起严重不良事件,24%在术后30天内发生,29%在90天内发生。在90天内发生的80次再入院中,28次(35%)发生在胰腺切除术后30天之后。

结论

约三分之一的严重不良事件和再入院发生在术后30天之后才被报告。必须识别并报告手术90天内发生的所有不良事件,以便准确描述与胰腺切除术相关的发病率。

相似文献

1
Active Surveillance for Adverse Events Within 90 Days: The Standard for Reporting Surgical Outcomes After Pancreatectomy.90天内不良事件的主动监测:胰十二指肠切除术后手术结果报告的标准
Ann Surg Oncol. 2015 Oct;22(11):3522-9. doi: 10.1245/s10434-015-4437-z. Epub 2015 Feb 19.
2
Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality.胰腺癌术前放化疗不会增加术后90天的发病率或死亡率。
J Gastrointest Surg. 2016 Dec;20(12):1975-1985. doi: 10.1007/s11605-016-3286-9. Epub 2016 Oct 11.
3
Laparoscopic left pancreatectomy: complication risk score correlates with morbidity and risk for pancreatic fistula.腹腔镜下左半胰切除术:并发症风险评分与发病率及胰瘘风险相关。
Ann Surg Oncol. 2009 Oct;16(10):2825-33. doi: 10.1245/s10434-009-0597-z. Epub 2009 Jul 16.
4
Does Pancreatic Stump Closure Method Influence Distal Pancreatectomy Outcomes?胰腺残端闭合方法会影响胰体尾切除术的结果吗?
J Gastrointest Surg. 2015 Aug;19(8):1449-56. doi: 10.1007/s11605-015-2825-0. Epub 2015 Apr 23.
5
Postoperative narcotic use is associated with development of clinically relevant pancreatic fistulas after distal pancreatectomy.术后使用麻醉剂与远端胰腺切除术后发生临床相关胰瘘有关。
Surgery. 2018 Apr;163(4):747-752. doi: 10.1016/j.surg.2017.10.042. Epub 2017 Dec 18.
6
Adding days spent in readmission to the initial postoperative length of stay limits the perceived benefit of laparoscopic distal pancreatectomy when compared with open distal pancreatectomy.与开腹远端胰腺切除术相比,将再入院天数计入初始术后住院时间会限制腹腔镜远端胰腺切除术的感知益处。
Am J Surg. 2011 Mar;201(3):295-9; discussion 299-300. doi: 10.1016/j.amjsurg.2010.09.014.
7
Readmission after pancreatectomy for pancreatic cancer in Medicare patients.医疗保险患者胰腺癌胰切除术的再次入院。
J Gastrointest Surg. 2009 Nov;13(11):1963-74; discussion 1974-5. doi: 10.1007/s11605-009-1006-4. Epub 2009 Sep 16.
8
A comparative analysis of postoperative pancreatic fistulas after surgery with and without hyperthermic intraperitoneal chemoperfusion.有或无术中腹腔热灌注化疗的手术后胰瘘的对比分析
Ann Surg Oncol. 2015 May;22(5):1651-7. doi: 10.1245/s10434-014-4186-4. Epub 2014 Oct 28.
9
Factors affecting readmission rates after pancreatectomy.影响胰腺切除术后再入院率的因素。
J Hepatobiliary Pancreat Sci. 2020 Apr;27(4):182-190. doi: 10.1002/jhbp.706. Epub 2020 Feb 16.
10
After Pancreatectomy, the “90 Days from Surgery” Definition Is Superior to the “30 Days from Discharge” Definition for Capture of Clinically Relevant Readmissions.胰腺切除术后,对于捕捉临床相关再入院情况而言,“术后90天”的定义优于“出院后30天”的定义。
J Gastrointest Surg. 2016 Jan;20(1):77-84; discussion 84. doi: 10.1007/s11605-015-2984-z.

引用本文的文献

1
Institutional learning curve and factors of prolonged operation time of robotic distal pancreatectomy: An analysis of an initial 117 cases.机器人远端胰腺切除术的机构学习曲线及手术时间延长的因素:对最初117例病例的分析
Ann Gastroenterol Surg. 2025 Feb 24;9(4):861-869. doi: 10.1002/ags3.70005. eCollection 2025 Jul.
2
Impact of Nonhepatectomy Opioid Reduction Efforts on Posthepatectomy Opioid Prescription: Analysis of 2,005 Patients.非肝切除手术中阿片类药物减量措施对肝切除术后阿片类药物处方的影响:对2005例患者的分析
J Am Coll Surg. 2025 Apr 1;240(4):474-487. doi: 10.1097/XCS.0000000000001279. Epub 2025 Mar 17.
3
The Impact of Intraoperative Anesthesiology Provider Handovers on Postoperative Complications After Hepatopancreatobiliary (HPB) Surgery.术中麻醉医生交接对肝胆胰(HPB)手术后并发症的影响。
J Surg Oncol. 2025 Mar;131(3):457-464. doi: 10.1002/jso.27941. Epub 2024 Oct 10.
4
Study protocol of the FRENCH24-ANIS study: postoperative anti-infective strategy following pancreaticoduodenectomy in patients with preoperative biliary stents-an intergroup FRENCH-ACHBT-SFAR prospective randomized controlled trial.FRENCH24-ANIS 研究方案:术前胆道支架置入的胰十二指肠切除术后抗感染策略——一项 FRENCH-ACHBT-SFAR 分组前瞻性随机对照试验。
BMC Surg. 2024 Aug 22;24(1):237. doi: 10.1186/s12893-024-02507-y.
5
Assessing Intra-abdominal status for clinically relevant postoperative pancreatic fistula based on postoperative fluid collection and drain amylase levels after distal pancreatectomy.基于胰体尾切除术后的腹腔积液和引流液淀粉酶水平评估与临床相关的术后胰瘘的腹腔内状况。
Ann Gastroenterol Surg. 2023 Sep 18;8(2):321-331. doi: 10.1002/ags3.12741. eCollection 2024 Mar.
6
Evaluation and Recalibration of Risk-Stratified Pancreatoduodenectomy Drain Fluid Amylase Removal Criteria.风险分层胰十二指肠切除术引流液淀粉酶清除标准的评估和重新校准。
J Gastrointest Surg. 2023 Dec;27(12):2806-2814. doi: 10.1007/s11605-023-05863-x. Epub 2023 Nov 7.
7
Photodynamic Stromal Depletion in Pancreatic Ductal Adenocarcinoma.胰腺导管腺癌中的光动力基质耗竭
Cancers (Basel). 2023 Aug 16;15(16):4135. doi: 10.3390/cancers15164135.
8
Incidence of Postoperative Complications Following Pancreatectomy for Pancreatic Cystic Lesions or Pancreatic Cancer.胰腺囊性病变或胰腺癌胰腺切除术后的并发症发生率
J Gastrointest Surg. 2023 Feb;27(2):319-327. doi: 10.1007/s11605-022-05534-3. Epub 2022 Nov 29.
9
Comparative analysis of opioid use between robotic and open pancreatoduodenectomy.机器人与开放胰十二指肠切除术的阿片类药物使用比较分析。
J Hepatobiliary Pancreat Sci. 2023 Apr;30(4):523-531. doi: 10.1002/jhbp.1216. Epub 2022 Jul 15.
10
Prognostic significance of preoperative and postoperative CA 19-9 normalization in pancreatic adenocarcinoma treated with neoadjuvant therapy or surgery first.新辅助治疗或手术先行治疗胰腺腺癌时术前和术后 CA 19-9 正常化的预后意义。
J Surg Oncol. 2022 Nov;126(6):1021-1027. doi: 10.1002/jso.26989. Epub 2022 Jun 20.

本文引用的文献

1
Ninety-day Postoperative Mortality Is a Legitimate Measure of Hepatopancreatobiliary Surgical Quality.术后90天死亡率是衡量肝胆胰外科手术质量的合理指标。
Ann Surg. 2015 Dec;262(6):1071-8. doi: 10.1097/SLA.0000000000001048.
2
Establishing a quantitative benchmark for morbidity in pancreatoduodenectomy using ACS-NSQIP, the Accordion Severity Grading System, and the Postoperative Morbidity Index.利用 ACS-NSQIP、风琴式严重程度分级系统和术后并发症指数,为胰十二指肠切除术建立发病率的定量基准。
Ann Surg. 2015 Mar;261(3):527-36. doi: 10.1097/SLA.0000000000000843.
3
Nurse practitioner and physician assistant scope of practice in 118 acute care hospitals.118家急症医院中执业护士与医师助理的执业范围。
J Hosp Med. 2014 Oct;9(10):615-20. doi: 10.1002/jhm.2231. Epub 2014 Sep 16.
4
The 90-day mortality after pancreatectomy for cancer is double the 30-day mortality: more than 20,000 resections from the national cancer data base.胰腺癌胰腺切除术后90天死亡率是30天死亡率的两倍:来自国家癌症数据库的超过20000例切除术。
Ann Surg Oncol. 2014 Dec;21(13):4059-67. doi: 10.1245/s10434-014-4036-4. Epub 2014 Sep 5.
5
Variations in definition and method of retrieval of complications influence outcomes statistics after pancreatoduodenectomy: comparison of NSQIP with non-NSQIP methods.胰十二指肠切除术后并发症定义及检索方法的差异影响结果统计:NSQIP与非NSQIP方法的比较
J Am Coll Surg. 2014 Sep;219(3):407-15. doi: 10.1016/j.jamcollsurg.2014.01.064. Epub 2014 Apr 18.
6
Measuring surgical quality: a national clinical registry versus administrative claims data.衡量手术质量:国家临床登记系统与行政索赔数据的比较
J Gastrointest Surg. 2014 Aug;18(8):1416-22. doi: 10.1007/s11605-014-2569-2. Epub 2014 Jun 14.
7
Using a modification of the Clavien-Dindo system accounting for readmissions and multiple interventions: defining quality for pancreaticoduodenectomy.采用一种改良的 Clavien-Dindo 系统,同时考虑再入院和多次干预:定义胰十二指肠切除术的质量。
J Surg Oncol. 2014 Sep;110(4):400-6. doi: 10.1002/jso.23663. Epub 2014 May 26.
8
Limitations of ACS-NSQIP in reporting complications for patients undergoing pancreatectomy: underscoring the need for a pancreas-specific module.美国外科医师学会国家外科质量改进计划(ACS-NSQIP)在报告胰腺切除患者并发症方面的局限性:强调需要一个胰腺特异性模块。
World J Surg. 2014 Jun;38(6):1461-7. doi: 10.1007/s00268-013-2439-1.
9
The impact of postoperative complications on long-term quality of life after curative colorectal cancer surgery.根治性结直肠癌手术后术后并发症对长期生活质量的影响。
Ann Surg. 2014 May;259(5):916-23. doi: 10.1097/SLA.0000000000000407.
10
A randomized prospective multicenter trial of pancreaticoduodenectomy with and without routine intraperitoneal drainage.随机前瞻性多中心试验:胰十二指肠切除术联合与不联合常规腹腔引流的效果比较。
Ann Surg. 2014 Apr;259(4):605-12. doi: 10.1097/SLA.0000000000000460.